Mansanades, Juliet J.

HRN: 22-77-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/22/2023
03/29/2023
IVT
600mg
Q8H
Empiric
Waiting Final Action 
03/23/2023
CLINDAMYCIN 300MG (CAP)
03/23/2023
03/29/2023
ORAL
300 Mg
Q6
Open Wound At Left Breast
Waiting Final Action 
03/25/2023
CEFTRIAXONE 1G (VIAL)
03/25/2023
03/31/2023
IV
2gm
OD
Pneumonia
Waiting Final Action 
03/29/2023
AZITHROMYCIN 500MG TABLET (TAB)
03/29/2023
04/03/2023
PO
500mg
OD
Empiric
Waiting Final Action 
03/30/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/30/2023
03/30/2023
IV
4.5 G Loading Dose
Now
Infected Wound Of The Left Breast
Waiting Final Action 
03/30/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/30/2023
04/06/2023
IV
2.25g
Q6h
Infected Wound Of The Left Breast
Waiting Final Action 
03/31/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/31/2023
04/06/2023
IV
4.5gms
Q8
Empirical Escalation
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: